Exact Mass: 348.1811
Exact Mass Matches: 348.1811
Found 200 metabolites which its exact mass value is equals to given mass value 348.1811,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
(1S,2S,4S)-1,8-Epoxy-p-menthane-2,7-diol 2-O-b-D-glucoside
(1S,2S,4S)-1,8-Epoxy-p-menthane-2,7-diol 2-O-b-D-glucoside is found in herbs and spices. (1S,2S,4S)-1,8-Epoxy-p-menthane-2,7-diol 2-O-b-D-glucoside is a constituent of Foeniculum vulgare (fennel) Constituent of Foeniculum vulgare (fennel). (1S,2S,4S)-1,8-Epoxy-p-menthane-2,7-diol 2-O-b-D-glucoside is found in herbs and spices.
Foeniculoside VIII
Foeniculoside VIII is found in herbs and spices. Foeniculoside VIII is a constituent of Foeniculum vulgare (fennel). Constituent of Foeniculum vulgare (fennel). Foeniculoside VIII is found in herbs and spices.
Foeniculoside V
Foeniculoside V is found in herbs and spices. Foeniculoside V is a constituent of Foeniculum vulgare (fennel).
Foeniculoside IX
Constituent of Foeniculum vulgare (fennel). (1S,2S,4S,5R)-1,8-Epoxy-p-menthane-2,5-diol 2-O-b-D-glucoside is found in herbs and spices. Foeniculoside IX is found in herbs and spices. Foeniculoside IX is a constituent of Foeniculum vulgare (fennel).
Nepetariaside
Nepetariaside is found in herbs and spices. Nepetariaside is a constituent of Nepeta cataria (catnip). Constituent of Nepeta cataria (catnip). Nepetariaside is found in tea and herbs and spices.
Foeniculoside VII
Foeniculoside VII is found in herbs and spices. Foeniculoside VII is a constituent of Foeniculum vulgare (fennel). Constituent of Foeniculum vulgare (fennel). Foeniculoside VII is found in herbs and spices.
cis-10-Hydroxylinalyl oxide 7-glucoside
cis-10-Hydroxylinalyl oxide 7-glucoside is found in herbs and spices. cis-10-Hydroxylinalyl oxide 7-glucoside is a constituent of Foeniculum vulgare (fennel). Constituent of Foeniculum vulgare (fennel). trans-10-Hydroxylinalyl oxide 7-glucoside is found in herbs and spices.
(1S,2S,4S,5S)-2,4,7-Thujanetriol 4-glucoside
(1S,2S,4S,5S)-2,4,7-Thujanetriol 4-glucoside is found in herbs and spices. (1S,2S,4S,5S)-2,4,7-Thujanetriol 4-glucoside is a constituent of Foeniculum vulgare (fennel). Constituent of Foeniculum vulgare (fennel). (1S,2S,4S,5S)-2,4,7-Thujanetriol 4-glucoside is found in herbs and spices.
(1S,2S,4R)-p-Menth-8-ene-1,2,10-triol 2-glucoside
(1S,2S,4R)-p-Menth-8-ene-1,2,10-triol 2-glucoside is found in herbs and spices. (1S,2S,4R)-p-Menth-8-ene-1,2,10-triol 2-glucoside is isolated from caraway fruit. Isolated from caraway fruit. (1S,2S,4R)-p-Menth-8-ene-1,2,10-triol 2-glucoside is found in herbs and spices.
(1S,2S,4R,5S,7S)-2,5,7-Fenchanetriol 2-O-b-D-glucoside
(1S,2S,4R,5S,7S)-2,5,7-Fenchanetriol 2-O-b-D-glucoside is found in herbs and spices. (1S,2S,4R,5S,7S)-2,5,7-Fenchanetriol 2-O-b-D-glucoside is a constituent of Foeniculum vulgare (fennel). Constituent of Foeniculum vulgare (fennel). (1S,2S,4R,5S,7S)-2,5,7-Fenchanetriol 2-O-b-D-glucoside is found in herbs and spices.
Acrivastine
R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist Acrivastine is a second-generation alkylamine H1-antihistamine. Acrivastine (BW825C) is a short acting histamine 1 receptor antagonist for the treatment of allergic rhinitis.
3-[6-[1-(4-Methylphenyl)-3-pyrrolidin-1-ylprop-1-enyl]pyridin-2-yl]prop-2-enoic acid
alpha-(4-Fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants BMY 14802 is a sigma-1 receptor (σ1R) antagonist, as well as an agonist at serotonin (5-HT) 1A and adrenergic alpha-1 receptors. BMY 14802 inhibits abnormal involuntary movement (AIM) in rat Parkinson's disease (PD) model, with down-regulating the expression of AIM[1][2].
2-O-beta-D-Glucopyranoside-(1S,2R,4R,5S)-2,4,5-Bornanetriol
4R-p-menth-1-ene-7,8-diol 7-O-beta-D-glucopyranoside
(1S,4S,8S)-8,9-Dihydroxytetrahydrocarvone 9-O-??-D-glucopyranoside
1-(4-ethyl-12-methyl-3,3a,10,11,12,12a-hexahydro-2H-furo[3,2:5,6]pyrido[3,4-a]carbazol-2-yl)-ethanone|Subincanin|Subincanine
10-hydroxy-2E-decenoic acid 10-O-beta-D-glucopyranoside
O1-((1Xi,3Xi,4Xi)-8-hydroxy-p-menthan-3-yl)-beta-D-glucopyranuronic acid|O1-((1Xi,3Xi,4Xi)-8-Hydroxy-p-menthan-3-yl)-beta-D-glucopyranuronsaeure
(1S,2R,4S)-p-menth-5-ene-1,2,4-triol 2-O-beta-D-glucopyranoside|(1S,2R,4S)-p-Menth-5-ene-1,2,4-triol 2-O-??-D-glucopyranoside
(beta-D-Glucopyranosyl)-8-hydroxy-2,6-dimethyloct-2-enoat
(6Z)-3-hydroxymethyl-7-methylocta-1,6-dien-3-ol 8-O-beta-D-glucopyranoside
(3R,4R,6R)-p-Menth-1-ene-3,4,6-triol 3-O-??-D-glucopyranoside
(1S,2S,4S,6R,7S)-2,6,7-trihydroxyfenchane 2-O-beta-D-glucopyranoside
3-phenyl-N-[4-(3-phenylprop-2-enoylamino)butyl]prop-2-enamide
4R-p-menth-1-ene-7,8-diol 8-O-beta-D-glucopyranoside
Foeniculoside VIII
Foeniculoside IX
(1S,2S,4R,5S,7S)-2,5,7-Fenchanetriol 2-O-b-D-glucoside
cis-10-Hydroxylinalyl oxide 7-glucoside
(1S,2S,4S,5S)-2,4,7-Thujanetriol 4-glucoside
(1S,2S,4S)-1,8-Epoxy-p-menthane-2,7-diol 2-O-b-D-glucoside
Foeniculoside V
Daunosamine
(1S,2S,4R)-p-Menth-8-ene-1,2,10-triol 2-glucoside
Foeniculoside VII
Kytril
C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist > C94726 - 5-HT3 Receptor Antagonist D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents Granisetron (Hydrochloride) (BRL 43694A) is a serotonin 5-HT3 receptor antagonist used as an antiemetic to treat nausea and vomiting following chemotherapy.
Sodium dodecylbenzenesulfonate
Surfactant for use in washing or lye peeling of fruit and vegetables and in poultry scald solutions
Efinaconazole
D - Dermatologicals > D01 - Antifungals for dermatological use > D01A - Antifungals for topical use > D01AC - Imidazole and triazole derivatives D000890 - Anti-Infective Agents > D000935 - Antifungal Agents C254 - Anti-Infective Agent > C514 - Antifungal Agent
Benzamide, N-(1,1-dimethylethyl)-3-nitro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-
sodium,4-(4,6,8-trimethylnonan-3-yl)benzenesulfonate
ETHYL 4-((TERT-BUTYLDIMETHYLSILYL)OXY)-1-(2-CHLOROETHYL)CYCLOHEXANECARBOXYLATE
(E)-METHYL 3-(4-(((2-(2-METHYL-1H-INDOL-3-YL)ETHYL)AMINO)METHYL)PHENYL)ACRYLATE
ethyl (3R,5S)-4-acetamido-5-amino-3-pentan-3-yloxycyclohexene-1-carboxylate,hydrochloride
ethyl dibunate
C78273 - Agent Affecting Respiratory System > C66917 - Antitussive Agent
2,6-Bis[(2-hydroxy-5-methylphenyl)methyl]-4-methylphenol
N~3~-Cyclopropyl-N~4~-(Cyclopropylmethyl)-6-Methylbiphenyl-3,4-Dicarboxamide
5-((Benzyloxy)methyl)-7-(pyrrolidin-1-ylmethyl)quinolin-8-ol
2-(4-Ethylpiperazin-1-yl)-4-(phenylamino)pyrazolo[1,5-a][1,3,5]triazine-8-carbonitrile
1-[1-(3-Phenylacryloyl)spiro[1-benzofuran-3,4-piperidin]-5-yl]methanamine
Acrivastine
R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist Acrivastine (BW825C) is a short acting histamine 1 receptor antagonist for the treatment of allergic rhinitis.
(E)-3-[6-[(Z)-1-(4-methylphenyl)-3-pyrrolidin-1-ylprop-1-enyl]pyridin-2-yl]prop-2-enoic acid
D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists
1-[(2-Methylphenyl)methyl]-4-[[2-(trifluoromethyl)phenyl]methyl]piperazine
N-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(1-piperidinyl)ethyl]-3-oxanyl]ethanesulfonamide
N-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(1-piperidinyl)ethyl]-3-oxanyl]ethanesulfonamide
6,7,8,15,16,17-Hexahydro-7,16-methanodinaphtho(2,3-A:2,3-F)cyclodecene
alpha-(4-Fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants BMY 14802 is a sigma-1 receptor (σ1R) antagonist, as well as an agonist at serotonin (5-HT) 1A and adrenergic alpha-1 receptors. BMY 14802 inhibits abnormal involuntary movement (AIM) in rat Parkinson's disease (PD) model, with down-regulating the expression of AIM[1][2].
(2e,6s)-2,6-dimethyl-8-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oct-2-enoic acid
(14e,20z)-tricosa-14,20-dien-3,5,10,12,22-pentayne-1,2,16-triol
(14z,20z)-tricosa-14,20-dien-3,5,10,12,22-pentayne-1,2,16-triol
tricosa-14,20-dien-3,5,10,12,22-pentayne-1,2,16-triol
(1r,3as,3bs,8s,9s,9ar,9bs,11ar)-8-chloro-1-ethenyl-9-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,5h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one
(2r,3r,4s,5s,6r)-2-{[(3r,4r)-3-hydroxy-4-(2-hydroxypropan-2-yl)cyclohex-1-en-1-yl]methoxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(6s,8as,12as,12bs)-4-chloro-6,9,9,12b-tetramethyl-5,6,7,8,8a,10,11,12-octahydro-oxatetraphen-3-ol
methyl 15-(3-hydroxy-2-methylphenyl)pentadeca-2,4,6,8,10,12,14-heptaenoate
(2s,3r,4s,5s,6r)-2-{[(1r,4r,6r)-4-hydroxy-1,3,3-trimethyl-2-oxabicyclo[2.2.2]octan-6-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
6-{[(2e)-3,7-dimethylocta-2,6-dien-1-yl]oxy}phenazin-1-ol
(1r,2s,5r,7s)-2-[(3as,4s,7ar)-4,7a-dimethyl-1,3-dioxo-tetrahydro-2-benzofuran-4-yl]-7-fluoro-6-methylidenebicyclo[3.2.1]octane-1-carbaldehyde
10-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}dec-2-enoic acid
2-({4,5-dihydroxy-1,7,7-trimethylbicyclo[2.2.1]heptan-2-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol
10-hydroxylinalyl oxide
{"Ingredient_id": "HBIN000146","Ingredient_name": "10-hydroxylinalyl oxide","Alias": "NA","Ingredient_formula": "C16H28O8","Ingredient_Smile": "NA","Ingredient_weight": "348.392","OB_score": "NA","CAS_id": "219814-34-3","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "9427","PubChem_id": "NA","DrugBank_id": "NA"}
(1s,2r,4s)-p-menth-5-ene-1,2,4-triol 2-o-β-d-glucopyranoside
{"Ingredient_id": "HBIN003215","Ingredient_name": "(1s,2r,4s)-p-menth-5-ene-1,2,4-triol 2-o-\u03b2-d-glucopyranoside","Alias": "NA","Ingredient_formula": "C16H28O8","Ingredient_Smile": "CC(C)C1(CC(C(C=C1)(C)O)OC2C(C(C(C(O2)CO)O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "13762","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(1s,4s,8s)-8,9-dihydroxytetrahydrocarvone 9-o-β-d-glucopyranoside
{"Ingredient_id": "HBIN003298","Ingredient_name": "(1s,4s,8s)-8,9-dihydroxytetrahydrocarvone 9-o-\u03b2-d-glucopyranoside","Alias": "NA","Ingredient_formula": "C16H28O8","Ingredient_Smile": "CC1CCC(CC1=O)C(C)(COC2C(C(C(C(O2)CO)O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "6141","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(3r,4r,6r)-p-menth-1-ene-3,4,6-triol 3-o-β-d-glucopyranoside
{"Ingredient_id": "HBIN009526","Ingredient_name": "(3r,4r,6r)-p-menth-1-ene-3,4,6-triol 3-o-\u03b2-d-glucopyranoside","Alias": "NA","Ingredient_formula": "C16H28O8","Ingredient_Smile": "CC1=CC(C(CC1O)(C(C)C)O)OC2C(C(C(C(O2)CO)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "13761","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
